BioNTech SE BNTX Cash Flow Statement (2018-2026)

NASDAQ BNTX
$104.44 +1.56 (+1.52%)
As of: Sep 4, 2026 · 2:21 PM EDT
Reported Financials

BioNTech SE Quarterly Cash Flow Statement

Periods 32 quarters
Latest Jun 2026

BioNTech SE reported cash from operations of $0.01B and free cash flow of $0.08B for the quarter ended Jun 2026, down 92.6% year over year. This cash flow statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
7.22B7.16B7.11B3.17B3.13B4.15B0.98B-0.69B0.17B0.49B-0.34B-0.87B0.22B0.28B-0.44B-0.44B-0.03B-0.36B-0.62B-0.95B
Share-based CompensationStock Comp.
0.07B0.02B0.01B0.02B0.06B0.02B0.01B0.01B0.02B0.02B0.02B0.02B0.04B0.03B0.02B0.04B0.03B0.03B0.03B0.02B
Cash from Discontinued OperationsCash from Discont. Ops
1.77B-0.23B4.55B4.18B4.82B0.85B-0.73B4.78B0.88B0.92B-0.34B1.75B-0.70B-0.50B-0.82B0.17B0.91B0.36B-0.49B0.01B
Gains from Sales and DivestituresGains Divest
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Gains from Investment SecuritiesGains Investment
0.36B0.00B0.01B0.01B0.02B
Cash from OperationsCash from Ops.
1.77B0.23B4.55B4.18B4.82B0.85B-0.73B4.78B0.88B0.92B-0.34B1.75B-0.70B-0.50B-0.82B0.17B0.91B0.36B-0.49B0.01B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.06B0.03B0.03B0.04B0.03B0.03B0.03B0.03B0.04B0.08B0.04B0.05B0.05B0.18B0.05B0.06B0.15B0.19B0.14B0.31B
Change in Working Capital
Change in ReceivablesChange Receivables
-11.91B-1.96B-0.45B3.39B5.06B-0.66B0.96B0.69B4.45B1.72B-0.91B-0.94B0.59B1.03B0.09B0.50B
Change in InventoryChange Inventory
-0.39B-0.12B0.05B0.10B0.07B-0.15B0.02B-0.03B0.04B0.06B0.01B0.01B0.04B0.02B0.04B0.03B0.01B0.14B0.01B0.00B
Change in Accured ExpensesChange Accured Exp.
Change in TaxesChange Taxes
3.78B1.77B1.48B0.69B0.66B0.91B0.22B-0.24B0.07B0.22B-0.02B0.00B-0.04B0.04B-0.03B-0.02B0.06B0.09B-0.04B-0.04B
Investing Activities
Capital ExpendituresCapex
-0.10B-0.05B-0.05B-0.08B-0.08B-0.14B-0.05B-0.07B-0.06B-0.09B-0.06B-0.10B-0.08B-0.07B-0.05B-0.03B-0.04B-0.07B-0.07B-0.06B
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in IntangiblesChange Intangibless
-0.43B-0.01B0.42B0.33B0.98B2.96B2.53B3.18B2.96B4.68B1.85B2.31B1.68B5.01B2.33B
Acquisitions
-0.02B-0.37B-0.08B0.31B
Divestments
-0.48B-0.11B0.32B-0.08B-0.08B-0.16B-0.79B-2.50B-1.34B-2.90B-2.50B-0.26B-0.16B0.65B1.31B-0.07B-1.08B-3.17B3.10B-0.12B
Cash from Investing ActivitiesCash from Investing
0.48B0.11B0.32B-0.08B-0.08B0.16B-0.79B-2.50B-1.34B-2.90B-2.50B-0.26B-0.16B0.65B1.31B-0.07B-1.08B-3.17B3.10B-0.12B
Financing Activities
Cash from Financing ActivitiesCash from Financing
-0.01B0.06B0.09B-0.83B-0.66B-0.07B-0.31B-0.18B-0.34B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.02B-0.01B-0.02B0.03B-0.13B
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
50.35B
Net Equity Issued and RepurchasedNet Equity Issued
0.19B-0.18B0.12B
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
-1.03B-0.49B
Additional items
Exchange Rate EffectFX Effect
0.06B-0.11B0.06B0.12B0.05B0.86B-0.03B0.10B0.07B-0.02B0.01B-0.00B-0.00B0.01B-0.02B0.01B-0.03B0.00B-0.00B-0.00B
Change in Cash
1.28B-0.82B4.96B3.26B4.08B0.62B-1.83B2.10B-0.80B-2.00B-2.86B1.47B-0.87B0.15B0.48B0.08B-0.18B-2.83B2.64B-0.23B
Beginning Cash Balance
Free Cash FlowFCF
1.87B0.27B4.60B4.26B4.90B0.99B-0.68B4.85B0.94B1.01B-0.28B1.85B-0.62B-0.42B-0.77B0.20B0.95B0.43B-0.43B0.08B
Net Cash FlowNCF
2.24B0.40B4.96B3.26B4.08B0.94B-1.83B2.10B-0.80B-2.00B-2.86B1.47B-0.87B0.15B0.48B0.08B-0.18B-2.83B2.64B-0.23B